Therefore, CYP11B1 inhibitors that can be regarded as a pharmacological approach to block cortisol biosynthesis have become another treatment for Cushing’s syndrome. The gene discussed is CYP11B1; the disease is Cushing syndrome due to macronodular adrenal hyperplasia.